DiaMedica Therapeutics Ratios (2018-2019) | DMAC

Ratios Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019
Profitability
EBT Margin (Quarter) -266.00%
EBIT Margin (Quarter) -297.40%
EBITDA Margin (Quarter) -277.40%
Operating Margin (Quarter) -297.40%
Net Margin (Quarter) -277.40%
FCF Margin (Quarter) -371.80%
Efficiency
Assets Average (Quarter) 16.92M14.15M11.92M
Equity Average (Quarter) 3.54M26.04M10.57M15.47M12.80M10.70M
Invested Capital (Quarter) -40.88M47.97M4.11M17.02M13.91M11.70M9.70M
Asset Utilization Ratio (Quarter) 0.030.04
Leverage & Solvency
Equity Ratio (Quarter) 0.930.900.910.88
Valuation
Enterprise Value (Quarter) -6.71M-5.73M-3.90M-16.82M-13.72M-10.97M-5.05M
Return Ratios
Return on Sales (Quarter) -2.77%-11.47%-16.67%-18.14%
Return on Capital Employed (Quarter) -0.57%-0.74%-1.02%
Return on Invested Capital (Quarter) -0.65%-0.58%-0.77%-1.03%
Return on Assets (Quarter) -0.49%-0.64%-0.85%
Return on Equity (Quarter) -0.54%-0.54%-0.71%-0.95%